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Abstract 25 
The Siberian hamster (Phodopus sungorus) is a seasonal mammal, exhibiting a suite of 26 
physiologically and behaviourally distinct traits dependent on the time of year and governed by 27 
changes in perceived day length (photoperiod). These attributes include significant weight loss, 28 
reduced food intake, gonadal atrophy, and pelage change with short day photoperiod as in winter. 29 
The central mechanisms driving seasonal phenotype change during winter are mediated by a 30 
reduced availability of hypothalamic tri-iodothyronine (T3), but downstream mechanisms 31 
responsible for physiological and behavioural changes are yet to be fully elucidated. With access 32 
to a running wheel (RW) in short photoperiod, Siberian hamsters which have undergone 33 
photoperiod mediated weight loss override photoperiod-drive for reduced body weight and regain 34 
weight similar to a hamster held in long days. These changes occur despite retaining the majority 35 
of hypothalamic gene expression profiles appropriate for short day hamsters. Utilising the 36 
somatostatin agonist pasireotide, we have recently provided evidence for an involvement of the 37 
growth hormone axis (GH axis) in the seasonal regulation of bodyweight. In the present study we 38 
employed pasireotide to test for the possible involvement of the GH axis in running wheel induced 39 
body weight regulation. Pasireotide successfully inhibited exercise stimulated growth in short day 40 
hamsters and this was accompanied by altered hypothalamic gene expression of key GH axis 41 
components. Our data provides support for an involvement of the GH axis in the RW response in 42 
Siberian hamsters.   43 
Introduction 44 
Many species that have evolved for life in a seasonally variable environment have developed 45 
physiological strategies to optimise survival. The Siberian hamster is well described for its ability 46 
to reduce energy expenditure in winter or short day photoperiod (SD), with a suite of physiological 47 
adaptations that include reduced body mass and food intake, cessation of reproduction, altered 48 
pelage and the ability to employ a controlled hypometabolic state in the form of daily torpor (1). 49 
These responses which occur naturally in the wild, can be induced in the laboratory by providing 50 
a shortened photoperiod length (2), allowing for the convenient investigation of underlying 51 
mechanisms driving these altered physiological processes. This seasonal phenotypic plasticity is 52 
underpinned by an alteration of hypothalamic gene expression primarily of deiodinase enzymes 53 
which regulate local thyroid hormone (T3) availability (3). In the Siberian hamster, approximately 54 
50% of SD weight loss comes from fat mass; the remaining is composed of lean, or fat-free mass 55 
(4, 5), and in male hamsters fat is mainly lost from abdominal depots (6).  This physiological 56 
response occurs in a variety of small mammals and was first observed in the seasonal common 57 
shrew by Dehnel and later termed Dehnel’s phenomenon (7, 8).   58 
In the Siberian hamster, Dehnel’s phenomenon is reversed by wheel running activity (4, 9-11), a 59 
phenomenon that has also been observed in the Syrian hamster (Mesocricetus auratus) (12-15) 60 
and gerbils (Meriones unguiculatus) (16). With  access to a running wheel (RW) the Siberian 61 
hamster will run for long durations during the normal active phase, and in response will increase 62 
food intake and gain weight (4, 10). This response occurs to a lesser extent in hamsters adapted to 63 
long day photoperiod (LD; 16:8 h light:dark), but is particularly apparent in hamsters adapted to 64 
SD (8:16 h light:dark) (10, 17).  SD hamsters undertaking RW exercise maintain photoperiod 65 
appropriate pelage while torpor is prevented and testicular atrophy is partially reversed, and at the 66 
same time will gain body mass so that over a period of weeks they increase to a size more 67 
appropriate for an LD hamster (4, 9, 11). This increase in body mass is composed of both lean and 68 
fat tissue (4, 11), accompanied by increased overall body length, bone length and mineral content 69 
(10, 11) and is thus indicative of somatic growth. Despite attaining LD metabolic physiology, SD 70 
exercised hamsters largely retain hypothalamic gene expression profiles of SD sedentary hamsters, 71 
with only evidence of a partial reversal of the photoperiod mediated reduction in Pomc gene 72 
expression and a slower temporal increase in arcuate nucleus (ARC), somatostatin (Srif) mRNA 73 
(8).  74 
Somatostatin is an inhibitory hormone that is expressed widely in the central nervous system and 75 
is an integral component of the growth hormone (GH) axis. The majority of SRIF projections from 76 
the hypothalamus to the median eminence are from neurons in the periventricular nucleus (PeVN), 77 
which play the main role in the regulation of pituitary GH secretion (18, 19). To positively regulate 78 
GH secretion, growth hormone-releasing hormone (GHRH) is produced in the ventromedial 79 
hypothalamus and ARC, with the latter being those neurons primarily projecting to the median 80 
eminence in order to reach the somatotrophs of the anterior pituitary via the hypophyseal portal 81 
system (20). 82 
 83 
Pasireotide (also called SOM230) is a somatostatin analogue that was developed to treat GH 84 
secreting pituitary tumours in acromegaly (21). Pasireotide acts with high affinity at 4 of the 5 85 
known somatostatin G-protein coupled receptor subtypes (SSTR1,2,3,5), with particularly high 86 
affinity for SSTR5 (22, 23). Pasireotide mimics the action of somatostatin, inhibiting the secretion 87 
of pituitary GH in human and rodent tissue in vitro (24), and GH and IGF-1 secretion in vivo, 88 
which is in turn accompanied by impaired body mass gain in rodents (25, 26). We have previously 89 
shown that following 7 weeks of administration to LD hamsters, pasireotide led to significant 90 
weight loss, accompanied by a decrease in circulating IGF-1. However, SD hamsters administered 91 
with pasireotide did not lose further weight, but when subsequently switched back to LD, 92 
pasireotide significantly inhibited weight re-gain stimulated by LD photoperiod. In addition, 93 
pasireotide altered hypothalamic expression of GH axis genes including Srif in the PeVN, Ghrh in 94 
the ARC and supressed a rise in circulating IGF-1, suggesting a key role for the GH axis in the 95 
regulation of seasonal body mass (27). In the Syrian hamster, reversal of photoperiod induced 96 
physiology by exercise is accompanied by growth and an increase in pulsatile secretion of several 97 
pituitary hormones including GH (28). Together with the aforementioned study, we hypothesised 98 
that the GH axis may also be involved in the RW stimulated weight gain demonstrated in the 99 
Siberian hamster. Therefore, we established an experiment to mirror our previous study, with 100 
pasireotide administered in a long acting release form (LAR – 28 day) to SD acclimated hamsters, 101 
given access to a RW instead of manipulating the photoperiod.  102 
 103 
Methods 104 
Animals and tissue collection 105 
All animal experiments and general husbandry were in accordance with the German Animal 106 
Welfare Act, and approved by the Lower Saxony State Office for Consumer Protection and Food 107 
Safety (license no. 12/1023). All experiments were performed using adult male Siberian hamsters 108 
from a colony maintained at the University of Veterinary Medicine, Hannover. Hamsters were 109 
bred under natural photoperiod at a latitude of 52°N under ambient temperatures, before transferral 110 
to artificial LD (16:8 h light:dark) after weaning. Food (hamster breeding diet, Altromin 7014, 111 
Lage, Germany) and water were available ad libitum throughout, supplemented by a weekly slice 112 
of apple, and during experiments the hamsters were singly housed. Overhead lighting was provided 113 
by fluorescent tubes (Lumilux LF11, Osram, Germany) resulting in a light intensity of ca. 200–114 
350 Lux at cage level. During the dark phase, illumination was limited to dim red light of <5 Lux 115 
(Osram, Darkroom red, 15 W). For hamsters provided with a running wheel (RW; 14.5cm inner 116 
diameter), wheel revolutions were registered and stored at 6 min intervals. For comparison, mean 117 
daily distance run per hamster, calculated over the 49 day experiment was compared. In the 118 
pasireotide experiment, further sub-analyses were carried out, with daily running distance 119 
compared over the course of the experiment, and to assess if the behavioural pattern differed over 120 
the course of the dark (active) phase, wheel revolutions in 2 h bins were compared, taking the 121 
mean wheel revolutions during each bin for each hamster over the 49 day experiment.  At the end 122 
of the experiments, in order to determine any acute effects of exercise, non-fasted hamsters were 123 
sacrificed by CO2 overdose followed by cervical dislocation in the dark (active) phase between 124 
zeitgeber time (ZT) 12 and 13, where ZT 0 and ZT8 corresponds to time of lights on and off 125 
respectively. This timing was chosen so that we could take into account potential changes in 126 
circulating hormone levels due to RW activity. The brain, and trunk blood (from which serum was 127 
prepared), were collected and stored at -70˚C before use. Testes and liver were dissected and 128 
immediately weighed. In the pasireotide experiment these were returned to carcasses, which were 129 
stored at -70˚C and later thawed for body composition analysis.  130 
 131 
Pasireotide RW experiment 132 
Thirty adult male Siberian hamsters were initially acclimated to SD (8:16 h light:dark) for 10 133 
weeks (69-72 days) before they received a subcutaneous dose of pasireotide LAR (Novartis, Basel 134 
Switzerland;160mg/kg based on weight on day of administration) or vehicle only. On the day of 135 
administration, hamsters were further split into running wheel and sedentary groups, of which one 136 
vehicle and one pasireotide group received a RW (RW-Vehicle, RW-Pasireotide both n=7) and 137 
the remaining two groups did not (Sedentary-Vehicle, Sedentary-Pasireotide, both n=8). 138 
Pasireotide and vehicle treatment was repeated 28 days following the first administration. Body 139 
mass was measured from day 2 onwards following pasireotide or vehicle treatment at 4-day 140 
intervals, and the change in body mass from the start of pasireotide or vehicle administration was 141 
calculated and compared. The initial ambient temperature of 22 ± 1°C was lowered to 20 ± 1°C 142 
on day 20 to better facilitate the expression of torpor, which has been reported elsewhere (29). 143 
Hamsters were sacrificed as described above, after 49 days (7 weeks) of treatment and/or running 144 
wheel access.  145 
Body composition of dissected hamsters (with brain removed) was determined by nuclear 146 
magnetic resonance imaging (MRI; Echo MRI™ Whole Body Composition Analyser, Echo 147 
Medical Systems, Houston, Texas). Previously frozen decapitated bodies were doubly sealed in 148 
plastic bags, sealed bags then disinfected and warmed to 37°C in a water bath before measurement. 149 
Three measurements per carcass were taken, and the mean of these measurements accepted. Data 150 
are compared directly and as a ratio of lean:fat mass. Serum glucose was determined by ACCU-151 
CHEK AVIVA glucose monitor and test strips. ELISAs were performed on thawed serum 152 
according to manufacturers’ instructions. Serum insulin concentration was measured using a rat 153 
insulin ELISA kit (Mercodia, Uppsala, Sweden; cat. no. 10-1250-01), with intra assay CVs of 154 
6.93% and 6.35%, and an inter assay CV of 6.65%. One RW-Vehicle sample was excluded due to 155 
a very high %CV between technical replicates, reducing this group to an n=6. 156 
 157 
12 week RW experiment 158 
Food intake and hypothalamic Ghrh mRNA expression was investigated in a 12-week RW 159 
experiment (4). Briefly, 48 adult male Siberian hamsters were acclimated to either LD or SD, as 160 
described above, for 2 weeks before given access to a RW (LD-RW, SD-RW; both n=10) or not 161 
(LD-C, n=10; SD-C, n=8). The hamsters were sacrificed as described above, after 84 days (12 162 
weeks) following RW introduction as described above. Body mass and RW revolutions were 163 
measured during the course of the experiment and terminal organ mass (liver and testes) were 164 
recorded. Due to the loss of one LD-RW slide during preparation, the Ghrh in situ experiment was 165 
reduced to n=9 for this group. Because of excessive crumbling of the food, food intake data was 166 
excluded for several hamsters, reducing sample sizes; SD-RW: n=4, SD-Sedentary: n=5, LD-RW: 167 
n=10, LD-Sedentary, n=9.  168 
 169 
Open flow Respirometry Experiments 170 
Sedentary hamsters were monitored for a period of 2 or 3 days between days 13-20 of the 171 
experiment, by open flow respirometry, carried out in their home cages with dimensions 24.5cm 172 
x 15cm x 15cm and a volume approximately 5.5L. VO2 and VCO2 were measured with a 173 
FOXBOX field gas analyser (Sable systems, NV, USA) at a flow rate of 35-40 L/hour. 174 
Measurements were taken every 1 in 6 minutes, for 5 hamsters per session, and were adjusted 175 
according to an air reference channel. The body mass specific metabolic rate and respiratory 176 
quotient (RQ) were calculated, taking the bodyweight as the mean from the two closest weigh 177 
dates (4 days apart).  178 
 179 
Riboprobe synthesis 180 
Riboprobes complementary to DNA sequence fragments were generated from Siberian hamster, 181 
mouse or rat brain cDNA by RT-PCR as previously described (3, 27, 30-32). Templates were 182 
generated by PCR amplification of the insert from plasmid DNA with M13 forward and reverse 183 
primers located 5’ upstream to polymerase transcription sites in host vectors. Approximately 184 
100ng of PCR product were used in an in vitro transcription reaction with T7, T3 or SP6 185 
polymerases as appropriate in the presence of 35S-uridine 5-triphosphate (Perkin-Elmer, Bucks, 186 
UK) for radioactive in situ hybridisation.   187 
 188 
In situ hybridisation 189 
Coronal hypothalamic sections were cryosectioned at 14µm and mounted on poly-L-lysine coated 190 
slides (ThermoScientific, Rockford, IL, USA). Radiolabelled in situ hybridisation was carried out 191 
as previously described (33).  Briefly, slides were fixed in 4% PFA-0.1 M PB, acetylated in 0.25 192 
% acetic anhydride-0.1 M triethanolamine, pH 8. Radioactive probes (approx. 106 counts per 193 
minute per slide) were applied to the slides in 70 μl hybridisation buffer containing 0.3 M NaCl, 194 
10 mM Tris-HCl (pH 8), 1 mM EDTA, 0.05% tRNA, 10 mM DTT, 0.02 % Ficoll, 0.02 % 195 
polyvinylpyrrolidone, 0.02 % BSA and 10 % dextran sulphate. Hybridisation was performed 196 
overnight (approx. 16 h) at 58˚C. The following day, slides were washed in 4 x SSC (1 x SSC is 197 
0.15 M NaCl, 15 mM sodium citrate), treated with Ribonuclease A (20 μg/μl) at 37°C and washed 198 
in SSC to a stringency of 0.1 x at 60˚C. Dehydrated slides were exposed to Biomax MR film 199 
(Kodak, Rochester, NY, USA) for 16 h – 14 days as appropriate. 200 
 201 
Image analysis 202 
Autoradiographic films were scanned at 600 d.p.i. to a computer running Image Pro Plus v. 6.8 or 203 
v. 7.0 (Media Cybernetics, Marlow, UK). Integrated optical density of mRNA expression was 204 
obtained in reference to a 14C microscale and measured in 2-5 sections per slide for each probe as 205 
appropriate, and the accumulated count (arbitrary units) was compared. For presentation purposes, 206 
integrated optical density is expressed relative to the sedentary-vehicle or LD-C group, whose 207 
value is defined as 1. 208 
Statistical Analysis 209 
Data are expressed as mean ± SEM and analysis was carried out using Minitab v. 15.0 (Minitab, 210 
PA, USA) or GraphPad Prism v. 7.0 (Graphpad, CA, USA). Statistical tests used were 2-way 211 
ANOVA (general linear model) with Tukey post hoc tests, or two sample t-tests unless stated. P-212 
values less than 0.05 were considered statistically significant. Where data did not conform to 213 
assumptions of an ANOVA, it was transformed by log10 or square root, and statistics were 214 
performed on transformed data (log10: serum glucose and insulin data; square root: Ghrh in situ 215 
data). When data could not be transformed to fit assumptions of the parametric test, Kruskall-216 
Wallis (KW) and/or Mann-Whitney (MW) tests were performed, these instances are indicated in 217 
the text as appropriate. RW time course data were compared by 2-way RM-ANOVA followed by 218 
Sidak’s multiple comparison tests for differences between pasireotide and vehicle data. 219 
Correlations between distance travelled and change in body mass were investigated by linear 220 
regression. For the change in body mass data, 2-way ANOVAs were carried out at each time point, 221 
with pasireotide and RW access as factors. 222 
 223 
Results 224 
Effect of pasireotide on RW activity stimulated weight gain, body composition and organ mass 225 
Representative actograms are shown in figure 1A, here the RW activity is double plotted by 226 
aligning two consecutive days horizontally and each 24h is plotted twice (34), with the full 49 days 227 
shown. Pasireotide treatment did not significantly alter the daily distance run by RW hamsters, 228 
(Vehicle: 24,458 ± 3945 revolutions, 11.14 ± 1.80 km; pasireotide: 32,947 ± 4520 revolutions, 229 
15.01 ± 1.93 km. p=0.185, figure 1B). RW hamsters can be expected to decrease daily wheel 230 
running activity over time (10), and despite a brief drop in activity following the 2nd injection for 231 
vehicle hamsters, pasireotide did not alter daily wheel running activity over the course of the 232 
experiment, with only an overall effect of time (F(48, 624)=2.038, p<0.001); however there were 233 
no significant effects in post hoc analyses (figure 1C). In order to detect if pasireotide altered the 234 
pattern of wheel running behaviour, mean revolutions per 2 h of the dark phase from the 49 235 
experimental days were compared. There was a significant time effect (F(7, 91)=30.31, p<0.001),  236 
with the greater amount of wheel running occurring in the first 10 h of the dark phase, but no 237 
overall significant pasireotide effect was detected. And despite a significant interaction (F(7, 238 
91)=2.722, p=0.013) at no individual 2 h time-point did vehicle and pasireotide RW activity 239 
significantly differ (figure 1D). Very little wheel running activity occurred during the light phase, 240 
and this did not differ with pasireotide (RW-Vehicle: 1.93±0.56 revolutions, RW-Pasireotide: 241 
1.56±0.65 revolutions).  242 
As expected, RW activity caused weight gain (figure 2A; day 49: F(1,26)=72.38, p<0.001), and 243 
the increase in body mass for RW-Vehicle hamsters reached significance compared to all others 244 
after only 10 days. Pasireotide attenuated RW induced weight gain (day 49: F(1,26)=13.58, 245 
p=0.001), with RW-pasireotide hamsters reaching significant weight gain compared to sedentary 246 
counterparts by day 34, and differing from all other groups by day 46. The RW stimulated weight 247 
gain was attenuated by pasireotide, demonstrated by a significant interaction between these factors 248 
(day 49: F(1,26)=6.05, p=0.021). No correlation was found between the cumulative distance run 249 
over the course of the experiment and change in body mass for either pasireotide or vehicle treated 250 
hamsters (figure 2B r2=0.004, p=0.894; r2=0.182, p=0.292 respectively). Furthermore, we 251 
determined whether pasireotide might directly alter energy expenditure using open flow 252 
respirometry. In sedentary animals, metabolic rate and respiratory quotient did not differ in 253 
pasireotide compared with vehicle treated animals, measured overall, or in either the light or dark 254 
phase (supplementary table 1 and supplementary figure 1). 255 
 256 
Overall, lean mass of dissected carcasses was significantly increased by RW activity 257 
(F(1,26)=35.78, p<0.001), and this was suppressed by pasireotide treatment (F(1,26)=13.94, 258 
p=0.001). There was a significant interaction between factors (F(1,26)=15.43, p=0.001); with the 259 
RW-vehicle hamsters having a greater lean mass than all other treatment combinations (p<0.001 260 
all comparisons; figure 2C). Fat mass was only raised by RW activity (F(1,26)=7.25, p=0.012; 261 
figure 2D). Since body composition is a relative measure, and that the final body mass overall 262 
differed dramatically between groups, the ratio of lean-to-fat mass in dissected carcasses was 263 
compared, and RW hamsters were found to have a small but significantly greater proportion of fat 264 
mass overall (sedentary-vehicle: 0.905:0.095 ± 0.017, sedentary-pasireotide: 0.872:0.128 ± 0.020, 265 
RW-vehicle: 0.861:0.139 ± 0.024, RW-pasireotide: 0.836:0.164 ± 0.012 lean:fat mass; 266 
F(1,26)=4.37, p=0.047; figure 2E).  267 
Paired testes mass was significantly increased by RW activity (KW; p<0.001) but not altered by 268 
pasireotide (KW; p=0.852) and within RW and sedentary groups there were no significant effects 269 
of pasireotide (figure 2F). Liver mass was used as an indicator of internal organ mass and was 270 
significantly increased by RW activity (figure 2G; F(1,26)=23.74, p<0.001), and the effect of 271 
pasireotide and interaction between treatments both approaching significance (F(1,26)=2.94, 272 
p=0.098 and F(1,26)=3.32, p=0.080 respectively; figure 2G). In post hoc analyses, RW-Vehicle 273 
hamsters had significantly greater liver mass than sedentary counterparts (p<0.001) but compared 274 
with RW-Pasireotide, this difference did not reach significance (p=0.098). Interestingly, when 275 
liver mass was compared as a proportion of body mass, the trend for a pasireotide effect was 276 
abolished and only the RW effect remained (F(1,26)=7.18, p=0.013; Sedentary-Vehicle: 277 
48.13±1.64mg/g; Sedentary-Pasireotide: 47.38±1.23mg/g; RW-Vehicle: 53.78±2.40mg/g; RW-278 
Pasireotide: 51.67±1.62mg/g). 279 
 280 
Effects of RW activity on serum glucose and insulin concentrations 281 
Terminal (non-fasted) glucose concentrations did not differ between any of the treatment groups 282 
(Figure 3A), however serum insulin was significantly raised in RW hamsters (F(1,25)=4.42, 283 
p=0.046) and this was independent of pasireotide treatment (figure 3B). 284 
 285 
Effect of RW activity and pasireotide hypothalamic mRNA expression 286 
Two key genes in the regulation of photoperiod regulated seasonal phenotype change are those 287 
encoding for deiodinase enzymes types II and III (Dio2 and Dio3) which regulate central 288 
availability of active thyroid hormone.  In accordance with previous work (4, 27), when measured 289 
by in situ hybridization, expression of neither Dio2 nor Dio3 differed with RW activity or 290 
pasireotide treatment (figures 4A and 4B respectively). Since RW stimulated weight gain in the 291 
Siberian hamster is accompanied by increased food intake (4), expression of two appetite 292 
regulating peptides Pomc and Npy were measured in the ARC. Pomc expression was raised by 293 
RW activity independent of pasireotide (F(1,26)=13.05, p=0.001, figure 4C) and this was also the 294 
case for Npy  expression (F(1,26)=5.40, p=0.029; figure 4D).  295 
In order to determine whether the observed growth effects may be mediated by an alteration of the 296 
central growth hormone axis or by systemic feedback to this axis, hypothalamic expression of Srif 297 
in the ARC and PeVN as well as Ghrh and Gh-r in the ARC were measured. Arcuate nucleus Srif 298 
expression was not altered by RW activity or pasireotide, although a decrease with RW activity 299 
approached significance (F(1,26)=3.54, p=0.071; figure 4E). Srif expression in the PeVN was 300 
significantly increased with RW activity (F(1,26)=14.93, p=0.001) and decreased by pasireotide 301 
(F(1,26)=8.63 p=0.007; figure 4F). Expression of Ghrh in the ARC was increased only by RW 302 
activity (F(1,26)=5.44 p=0.028, figure 4G). Similarly, Gh-r expression in the ARC was unaltered 303 
by pasireotide and significantly increased overall in RW hamsters (F(1,26)=9.33, p=0.005; figure 304 
4H).  305 
 306 
Effect of RW on Ghrh expression and food intake in LD and SD hamsters  307 
In a second RW experiment, hamsters exposed to LD or SD for a period of two weeks before 12 308 
weeks of RW access, body weight was significantly decreased for the SD-Sedentary hamsters 309 
compared to all others by day 35 (p≤0.05). At the end of the experiment there were significant 310 
effects on body mass, with both photoperiod and RW activity, with interaction (Photoperiod: 311 
F(1,34)=16.46, p<0.001; RW Activity: F(1,34)=33.23, p<0.001; Interaction: F(1,34)=5.263, 312 
p=0.028 figure 5A). For the RW hamsters, photoperiod did not affect the mean distance run 313 
(figures 5B, C). As previously described (4), food intake increased for RW hamsters and with LD 314 
photoperiod, (Photoperiod: F(1,24)=5.15, p=0.033; RW Activity: F(1,24)=50.71, p<0.001; 315 
Interaction: F(1,24)=0.09, p=0.764, supplementary figure 2). As expected, paired testes mass was 316 
significantly reduced in SD hamsters with no overall effect of RW activity (KW; Photoperiod: 317 
H=27.08, p<0.001; RW Activity: p=0.279). However, in pairwise comparisons both SD-Sedentary 318 
and SD-RW hamsters had significantly different paired testes mass compared to all other groups 319 
(MW; p<0.001, all comparisons), with the SD-RW hamsters having a mid-range mass compared 320 
to the SD-Sedentary and LD hamsters (figure 5D). RW access significantly increased liver mass, 321 
with interaction between RW access and photoperiod (Photoperiod: F(1,34)=2.19, p=0.148; RW 322 
Activity: F(1,34)=22.82, p<0.001; Interaction: F(1,34)=6.10, p=0.019), with SD-C having a lower 323 
liver mass than all other groups (vs. LD-C p=0.049; vs. SD-RW, p<0.001; vs. LD-RW p<0.001; 324 
figure E). Liver mass as a function of body mass did not significantly differ between groups (LD-325 
RW: 46.29 ± 1.50mg/g; LD-C 45.74 ± 1.65mg/g; SD-RW: 49.83 ± 3.01mg/g; SD-C: 44.53 ± 326 
0.63mg/g). 327 
Expression of ARC Ghrh was significantly raised by RW overall and with a trend for an effect of 328 
photoperiod (RW Activity: F(1,33)=8.18, p=0.007; Photoperiod: F(1,33)=3.32, p=0.078; 329 
Interaction: F(1,33)=0.85,  P=0.362, figure 5F). 330 
 331 
Discussion 332 
The present study aimed to provide evidence to support the hypothesis that the GH axis is involved 333 
in the exercise induced growth response of the Siberian hamster by disrupting the hypothesised 334 
stimulation of this axis with the somatostatin analogue, pasireotide and by measuring the 335 
expression of key GH axis components in the hypothalamus.  336 
Pasireotide treatment significantly retarded the body weight increase caused by access to a RW. 337 
Further, access to RW increased expression of Srif in the PeVN indicative of increased feedback 338 
to the inhibitory arm of the GH axis, and increased Ghrh expression in the ARC, indicative of 339 
increased stimulatory drive to the GH axis. Furthermore, pasireotide reduced the RW-induced Srif 340 
expression in the PeVN indicative of a reduction in GH feedback to the hypothalamus. Since 341 
pasireotide is not expected to cross the blood brain barrier, and reduces circulating IGF-1 (25-27), 342 
the most likely explanations for pasireotide retardation of RW induced growth are inhibition of 343 
GH secretion from the pituitary or inhibition of IGF-1 secretion from the liver, although as 344 
discussed below, other mechanisms may be involved. 345 
The RW response phenomenon may have evolved in this species in order to take advantage of 346 
favourable conditions such as a mild winter or an early spring to reproduce early and maximise 347 
offspring number and survival. Wheel running is not a natural behaviour but can represent a natural 348 
drive to be active. Indeed, running wheels placed in the wild are taken advantage of by a surprising 349 
variety of species (35) and it may be a self-rewarding behaviour. The hamsters of the present study 350 
ran for comparable distances to that previously reported (11) and any trend for reduced mean daily 351 
distance run in vehicle hamsters did not reach significance.  A temporary and non-significant 352 
decline in daily distance run by vehicle hamsters following the second administration may account 353 
for this apparent trend. As expected for animals housed in SD (36), further sub-analysis of daily 354 
RW activity over the dark period showed the peak of activity in the first of half of the night for all 355 
RW hamsters, independent of pasireotide. Therefore, we conclude that RW behaviour was largely 356 
unaltered by administration of the drug.  357 
In exercising SD hamsters, weight gain was retarded by pasireotide, with overall lean mass being 358 
similar to sedentary counterparts in contrast to the vehicle treated RW hamsters. Weight gain was 359 
however, not completely inhibited by pasireotide. A contribution to weight gain comes from fat 360 
mass which increased with RW activity and did not differ between vehicle and pasireotide 361 
treatments. Although we found no direct effect of pasireotide on metabolic energy expenditure in 362 
sedentary hamsters, it might be argued that a trend for increase in RW activity lead to increased 363 
energy expenditure and therefore the diversion of energy from growth. However, this explanation 364 
is unlikely since change in body mass did not correlate with the total distance run. Furthermore, 365 
fat mass would be the first source of additional energy mobilised for an increased energy 366 
expenditure (37), but this was similar in all RW hamsters.  367 
In the absence of altered energy expenditure, the retarded growth of RW-Pasireotide hamsters 368 
might be explained by a reduction in energy intake. One key component of the weight gain 369 
experienced by exercising hamsters is increased food intake (4, 10, 11). We did not measure food 370 
intake in the present pasireotide experiment, but clearly caloric intake was sufficient to sustain a 371 
similar increase in fat mass in vehicle and pasireotide treated hamsters. A lower food intake in 372 
pasireotide treated hamsters would likely occur because of a lower basal metabolic rate due to less 373 
lean tissue and less energy required to sustain RW induced muscle accretion and organ growth 374 
(38). This would also be consistent with a reduced orexigenic drive from the GH axis in the brain 375 
where GH has been shown to stimulate NPY neurons, and increase both Npy and Agrp expression 376 
(39-41).  377 
Food intake can be stimulated and suppressed by appetite regulating neuropeptides expressed in 378 
the hypothalamus, and POMC and NPY are both implicated in appetite control (42). In our 379 
previous study RW activity was accompanied by an increase in Pomc but no alteration of Npy 380 
expression (4). In the present study, in addition to an increase in Pomc, an increase in Npy 381 
expression was also observed. Increased Pomc expression may not necessarily equate to an 382 
increased anorexigenic drive as this may depend on the impact of RW activity on downstream 383 
processing enzymes which are photoperiodically regulated in a manner to increase anorexic α-384 
MSH production from POMC precursor peptide in SD (43). However, the discrepancy between 385 
these two findings for Npy may lie in the time of sampling, since hamsters in the present study 386 
were sacrificed during the dark RW active phase when an energy deficit due to activity will be 387 
greater in comparison with our previous study when hamsters were killed during the early light 388 
phase when hamsters were not exercising (4). 389 
Testicular atrophy was partially retarded in RW hamsters, with no significant effect of pasireotide 390 
treatment, suggesting RW activity had a broad stimulation of neuroendocrine axes. This is similar 391 
to a stimulatory effect of RW activity in Syrian hamsters where exercise has been shown to inhibit 392 
or reverse photoperiod induced reduction in prolactin, follicle-stimulating hormone, lueteinzing 393 
hormone and testosterone, and reverse reproductive quiescence (44, 45). Notably, RW stimulated 394 
growth was first observed in the Siberian hamster in castrated male animals (9), and so growth is 395 
unlikely to be driven by testosterone produced by the partially recrudesced testes of RW hamsters. 396 
Additionally, exercise induced growth has been demonstrated in both male and female Syrian 397 
hamsters (45) and Siberian hamsters (11).  398 
In line with previous work (4), insulin concentration was increased in serum of RW hamsters, 399 
although serum glucose levels did not differ. Any subtle differences in serum glucose might have 400 
been masked by the non-fasted state of the hamsters at sacrifice. Although the photoperiodic 401 
difference in circulating insulin in male Siberian hamsters is well established (4, 32), 402 
intraperitoneal glucose tolerance tests have revealed no photoperiod differences in glucose 403 
clearance for Siberian hamsters (46). A chronic difference in circulating insulin can be considered 404 
indicative of a more obese and generally insulin resistant state, as has been described for LD 405 
hamsters with regard to central insulin signalling (47). Insulin has a lipogenic activity in Siberian 406 
hamster adipocytes (48); therefore a greater concentration of insulin in the serum of RW hamsters 407 
may provide a mechanism for the increase and maintenance of fat deposition similar to a LD 408 
hamster, in addition to any insulin driven increase in lean mass (49). The lack of pasireotide effect 409 
on circulating insulin concentrations supports this interpretation, since fat mass was also 410 
unaffected.  411 
Alterations in the balance of the central thyroid hormone system are essential for driving seasonal 412 
phenotype change in the Siberian hamster (3, 50). However, as previously reported for RW (4) 413 
and pasireotide treated hamsters (27), there were no measurable effects on Dio2 and Dio3 414 
expression, indicating action downstream of the integration of the photoperiodic cue.  415 
Gh-r expression remained unaltered in the ARC by pasireotide, however there was a stimulatory 416 
effect of wheel running on expression of this receptor mRNA. This may have allowed for increased 417 
sensitivity to circulating GH, and suggests that tachyphylaxis of this receptor was not a problem 418 
with the hypothesised increase in circulating GH. Unfortunately, there was not enough remaining 419 
tissue to compare photoperiodic expression of GH-R and so it remains to be seen whether there is 420 
photoperiodic regulation of this receptor.  421 
In the present study, the effect of wheel running to stimulate increased ARC Ghrh expression was 422 
evident in both experiments, and in both LD and SD hamsters. Whereas we previously found that 423 
pasireotide significantly increased Ghrh expression in sedentary hamsters independent of 424 
photoperiod, the effect of pasireotide on Ghrh expression did not appear to be additive to the RW 425 
effect. Wheel running activity has been shown to suppress the SD stimulated increase in ARC Srif 426 
expression, an effect that appears to depend on the length of time that the hamsters had access to 427 
a RW and/or the length of time in SD photoperiod (4). Although not quite achieving significance, 428 
the present data demonstrated a trend to suppression by RW activity consistent with the previous 429 
study, but pasireotide did not alter ARC Srif expression. This indicates that pasireotide does not 430 
affect the photoperiodic drive on ARC Srif expression.  431 
As previously described (27) expression of Srif in the PeVN was suppressed by pasireotide. 432 
Together with increased Ghrh expression in the ARC by RW activity, the findings are consistent 433 
with altered feedback of the GH axis to these neurons. Although we cannot definitively conclude 434 
the primary driver of growth caused by RW activity is GH, the following support the notion GH 435 
underpins this mechanism; 1) robust increase in pulsatile circulating GH in Syrian hamsters caused 436 
by RW activity (28, 51); 2) the persistence of RW induced growth in castrated hamsters (9), 3) the 437 
known stimulatory effect of GH and suppressive effect of pasireotide on circulating IGF-1 levels 438 
in the Siberian hamster (27) and 4) suppressive effect of pasireotide on RW and LD photoperiod 439 
induced growth. However, due to insufficient serum we were unable to provide the definitive 440 
confirmation from measurement of circulating IGF-1 measurements. Thus any additional 441 
mechanism of inducing somatic growth may still be possible such as a contribution from increased 442 
circulating insulin (49), although evidence from Syrian hamsters suggests insulin is less likely to 443 
contribute to RW induced somatic growth (52). 444 
The seasonally adaptive physiology of the Siberian hamster has traditionally been studied as a tool 445 
to understand mechanisms for the regulation of appetite, body mass and metabolism. The exercise 446 
response that occurs in this species may be counterintuitive when considering that in general, 447 
exercise is known to have health promoting effects in human physiology across several different 448 
parameters. However even in human physiology, on an individual level there can be substantial 449 
variability in beneficial effects, or even detrimental effects of exercise on specific health 450 
parameters (53-56) that may be tied to compensatory eating (57). Considering the current level of 451 
reported obesity and overweight worldwide, with the main treatments being to reduce caloric 452 
intake and increase energy expenditure, it is important to understand how in certain individuals, 453 
specific exercise regimes or treatments might be beneficial to counteract poor exercise response. 454 
We propose that the Siberian hamster exercise response can be considered a model for poor 455 
exercise response in humans, typified by the increased serum insulin concentration, weight gain 456 
and no reduction in fat mass. Therefore, understanding what drives these physiological changes in 457 
the hamster could inform human medicine.  458 
 459 
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  644 
Figures 645 
Figure 1: Pasireotide does not alter distance run in SD acclimated Siberian hamsters with RW 646 
access. Representative double plotted actograms for a RW-vehicle and a RW-pasireotide hamster 647 
(A). Mean distance run / day / hamster over 49 d for hamsters treated with vehicle or pasireotide 648 
and access to a RW (B). Daily RW distance for pasireotide and vehicle hamsters (C), and mean 649 
wheel revolutions in 2 h bins during the dark phase over the course of the experiment (D).  n.s.: 650 
no significant differences. Both groups n = 7. Data are expressed as mean ± SEM. 651 
Figure 2: Pasireotide inhibits RW stimulated weight gain in SD acclimated Siberian hamsters. 652 
Body mass change (A) of hamsters acclimated to SD for 69-72 d before given access to a RW or 653 
not, and treated with pasireotide or vehicle for 49 d. (B) No correlation was found between distance 654 
travelled in 49 days and change in body mass in RW hamsters.  Carcass lean (C) and fat (D) tissue 655 
mass, measured by MRI, and relative lean and fat mass (E). Paired testes mass (F), and liver mass 656 
(G) at time of sacrifice are also shown. *p < 0.05, **p < 0.01, ***p<0.001, vs all other groups or 657 
as indicated; #: p<0.05 vs sedentary-pasireotide. †: p<0.001 vs RW-vehicle RW groups both n = 658 
7, sedentary groups both n = 8. Data are expressed as mean ± SEM. 659 
Figure 3: Pasireotide did not alter glucose homeostasis in SD acclimated Siberian hamsters. 660 
Terminal serum glucose (A) and insulin (B). *p < 0.05. RW-vehicle, n = 6; RW-pasireotide, n = 661 
7; sedentary groups, both n = 8. Data are expressed as mean ± SEM. 662 
Figure 4: RW stimulated increased gene expression of appetite regulating peptides and GH axis 663 
components, while pasireotide only altered expression of PeVN Srif. Relative mRNA expression 664 
of Dio2 (A), Dio3 (B), Pomc (C), Npy (D) and Srif (E) in the arcuate nucleus (ARC), Srif in the 665 
periventricular nucleus (PeVN; F), and Ghrh (G) and Gh-r (H) in the ARC. *p < 0.05, **p < 0.01, 666 
***p<0.001, n.s.: no significant differences. RW groups both n = 7, sedentary groups both n = 8. 667 
Data are expressed as mean ± SEM. 668 
Figure 5: RW access stimulates hypothalamic Ghrh expression in LD and SD hamsters. Siberian 669 
hamsters were acclimated to SD for 14 d or remained in LD before given access to a RW or not 670 
for a further 84 d. RW access caused a positive change in body mass (A), representative actograms 671 
for LD-RW and SD-RW hamsters for the full course of the experiment (B), and distance run / 672 
hamster / day (C). Terminal organ mass of paired testes (D) and liver (E), and relative Ghrh mRNA 673 
expression in the arcuate nucleus (F). *p < 0.05, ***p<0.001, vs all other groups, **p < 0.01 as 674 
indicated; #: p < 0.05 LD vs SD; †: p < 0.05 RW vs Sedentary. A-C, E, F: SD-sedentary, n = 8; all 675 
other groups n = 10. D: SD-RW: n=4, SD-Sedentary: n=5, LD-RW: n=10, LD-Sedentary, n=9. G: 676 
SD-sedentary n = 8, LD-RW n = 9, SD-RW and LD-sedentary both n = 10. Data are expressed as 677 
mean ± SEM. 678 
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Supplementary Material  
Somatostatin agonist pasireotide inhibits exercise stimulated growth in the male Siberian hamster 
(Phodopus sungorus) 
 
Open flow Respirometry Experiments 
Sedentary hamsters were monitored for a period of 2 or 3 days between days 13-20 of the experiment, by open 
flow respirometry, carried out in their home cages with dimensions 24.5cm x 15cm x 15cm and a volume 
approximately 5.5L. VO2 and VCO2 were measured with a FOXBOX field gas analyser (Sable systems, NV, USA) at 
a flow rate of 35-40 L/hour. Measurements were taken every 1 in 6 minutes, for 5 hamsters per session, and 
were adjusted according to an air reference channel. The body mass specific metabolic rate and respiratory 
quotient (RQ) were calculated, taking the bodyweight as the mean from the two closest weigh dates (4 days 
apart). Supplementary table 1 illustrate mean RQ over the measurement period, and supplementary figure 1 
demonstrates an example for vehicle and pasireotide treated sedentary hamsters over the course of a 2-day 
measurement period.  
Supplemental table 1: Respiratory quotient (RQ) is unchanged by pasireotide in sedentary hamsters.  
 Light Phase RQ Dark Phase RQ Overall RQ 
Pasireotide 0.846 ± 0.015 0.824 ± 0.012 0.831 ± 0.013 
Vehicle 0.821 ± 0.017 0.810 ± 0.012 0.813 ± 0.013 
 
Supplementary figure 1. 
 
Representative example metabolic rate and respiratory quotient (RQ) traces for a sedentary-vehicle and a 
sedentary-pasireotide hamster over 48h in the 3rd week of experiment. Grey bars indicate the dark phase, and 
a torpor bout is indicated for the sedentary-pasireotide hamster during the light phase on the 2nd measurement 
day. The effects of pasireotide on torpor in these hamsters has previously been discussed (1). 
 
 
Supplementary Figure 2: LD/SD experiment food intake data 
 
Food intake was measured on a weekly basis by weighing the difference in food weight in the cage hoppers, and 
plotted as cumulative food intake. Because of excessive crumbling of the food, food intake data was excluded 
for several hamsters, reducing sample sizes; SD-RW: n=4, SD-Sedentary: n=5, LD-RW: n=10, LD-Sedentary, n=9. 
As previously described (2), food intake increased for RW hamsters and with LD photoperiod, (Photoperiod: 
F(1,24)=5.15, p=0.033; RW Activity: F(1,24)=50.71, p<0.001; Interaction: F(1,24)=0.09, p=0.764, figure). #: p < 
0.05 LD vs SD; †: p < 0.05 RW vs Sedentary. 
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